Home » News » Drug Sponsors » Teva invests in $300M Philadelphia distribution center

Teva invests in $300M Philadelphia distribution center

Tuesday, September 27, 2011

Generic drug giant Teva Pharmaceutical, after years of a dramatic and sometimes controversial process to select a new home for its distribution center, is breaking ground on a $300 million building off Red Lion Road in Philadelphia, according to the Philadelphia Business Journal.  

The project consists of three buildings totaling 200,000 square feet. It is expected to be completed by the second half of 2013 and will employ more than 200 workers. Within three years Teva, which is based in Israel and has its U.S. headquarters in North Wales, Pa., is expected to add an additional 200 positions.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!